Use of plerixafor for hematopoietic stem cells mobilization in allograft donors

Use of plerixafor for hematopoietic stem cells mobilization in allograft donors

Show other versions (1)

Unsuccessful mobilization of hematopoietic stem cells (HSCs) before apheresis in allograft donor is a factor adversely affecting the characteristics of the obtained cell product and, as a consequence, the therapy outcome. This study investigates the efficacy and safety of plerixafor as an additional...

Full description

Bibliographic Details
Main Authors: D. N. Balashov, E. E. Kurnikova, M. A. Maschan, Yu. V. Skvortsov, L. N. Shelikhova, P. E. Trakhtman, E. V. Boyakova, E. V. Skorobogatova, G. A. Novichkova, A. A. Maschan
Format: Article
Language:Russian
Published: ABV-press 2015-01-01
Series:Onkogematologiâ
Subjects:
plerixafor
g-csf
allogeneic transplantation
hematopoietic stem cells
mobilization
alternative technology
donors
apheresis
efficacy
safety
side effects
Online Access:https://oncohematology.abvpress.ru/ongm/article/view/128

Internet

https://oncohematology.abvpress.ru/ongm/article/view/128

Similar Items